Skip to content

Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light

Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02899780
Enrollment
0
Registered
2016-09-14
Start date
2017-05-11
Completion date
2018-05-10
Last updated
2018-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-Related Infections

Brief summary

This study is a first-in-man clinical trial using fiber optically delivered ultraviolet light for reducing viable bacteria within indwelling tunneled dialysis catheters.

Interventions

DEVICEUltraviolet light emitting optical fiber

A ultraviolet light emitting optical fiber will be threaded through the existing catheter and withdrawn.

Sponsors

University of Maryland
CollaboratorOTHER
Ultraviolet Interventions
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be at least 18 years of age * Have the ability to provide informed consent * Have an implanted dialysis catheter of one of the following models: Medcomp Titan 15.5F x 24 cm or Medcomp Titan 15.5F x 28 cm * Positive blood culture drawn from the catheter

Exclusion criteria

* Previous inclusion in study * Pregnant

Design outcomes

Primary

MeasureTime frame
Quantitative reduction of bacterial counts from blood cultures drawn from the dialysis catheterMeasured immediately after UV treatment
Proportion of patients with any reduction of bacterial counts from blood cultures drawn from the dialysis catheterMeasured at study end, expected at 1 year.

Secondary

MeasureTime frame
Number of colony forming units (CFU) per cm2 of surface area on the inner lumen of removed cathetersMeasured after UV treatment, with results expected in 5 days.
Procedural complications, including excessive bleeding, infection, vascular injury, and significant catheter damage.Measured at study end, expected at 1 year.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026